This stock took it on the chops on aspirin “news” that does not affect the target market for Vazalore. PPS is almost where it was PRIOR to FDA approval, which is absurd.
$PLXP entry 15.95-18.20 Target PT 25 and higher Long term 100 and higher WAVE ANALYSIS CONSOLIDATION ABOVE THE RESISTANCE PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which...